期刊文献+

克罗米芬联合促卵泡素治疗30例多囊卵巢综合征的疗效分析 被引量:1

Analysis of the Effects of Clomiphene Citrate Combined with Follicle-stimulating Hormone in Treating 30 Patients with Polycystic Ovary Syndrome
下载PDF
导出
摘要 目的探讨分析克罗米芬联合促卵泡素在多囊卵巢综合征(PCOS)治疗中的疗效。方法回顾性分析该院就诊并确诊为PCOS的患者共60例,随机数法分为两组,对照组治疗方案:克罗米芬+人绒毛膜促性腺激素(HCG),观察组治疗方案:克罗米芬+促卵泡素+人绝经期促性腺激素(HMG)+HCG,排卵后黄体酮支持治疗两周,比较两组患者促排卵疗效。结果观察组患者排卵率和妊娠率均明显高于对照组(P<0.05);观察组患者治疗总有效率明显高于对照组(P<0.05)。结论克罗米芬联合促卵泡素治疗PCOS促排卵疗效确切,能够有效提高排卵率和妊娠率,推荐临床推广应用。 Objective To analyze the efficacy of clomiphene citrate combined with follicle-stimulating hormone in treating polycystic ovary syndrome(PCOS). Methods A total of 60 patients confirmedly diagnosed with PCOS in our hospital in the recent two years were analyzed retrospectively. They were randomly divided into 2 groups. The control group was given clomiphene citrate and human chorionic gonadotropin(HCG), and the observation group was given clomiphene citrate, follicle-stimulating hormone,human menopausal gonadotropin(HMG) and HCG. Progesterone was given to the patients for two weeks after ovulation as the supportive treatment. Then the therapeutic effects of ovulation induction of the two groups were compared. Results The ovulation rate and pregnancy rate of the observation group were significantly higher than those of the control group(P〈0.05), so as the total effective rate(P〈0.05). Conclusion Clomiphene citrate combined with follicle-stimulating hormone has definite effect of ovulation induction on PCOS, which can effectively improve the ovulation and pregnancy rate, and is recommended to be applied and promoted in the clinical practice.
作者 唐婷婷
出处 《中外医疗》 2014年第27期32-33,共2页 China & Foreign Medical Treatment
关键词 多囊卵巢综合征 克罗米芬 促卵泡素 促排卵 Polycystic ovary syndrome Clomiphene citrate Follicle-stimulating hormone Induction of ovulation
  • 相关文献

参考文献9

二级参考文献39

  • 1邢小燕,杨文英,杨兆军.胰岛素抵抗指数在不同糖耐量人群中诊断代谢综合征的作用[J].中国糖尿病杂志,2004,12(3):182-186. 被引量:127
  • 2甄秀梅,秦英慧,陈子江.多囊卵巢综合征的综合治疗新进展[J].国外医学(计划生育分册),2005,24(2):84-86. 被引量:13
  • 3姚宇玲,陈海燕.达英—35与二甲双胍联合应用治疗多囊卵巢综合征效果分析[J].海南医学,2006,17(5):114-115. 被引量:9
  • 4李艳萍,张琼,周庆娥,刘冬娥,刘能辉,邓利,陈仙花.来曲唑促排卵治疗的临床观察[J].生殖医学杂志,2006,15(3):150-152. 被引量:14
  • 5Yen HW,Jakimiuk AJ,Munir I,et al. Selective alterations in in- sulin receptor substrates - 1, - 2 and - 4 in theca but not granu- losa cells from polycystic ovaries. Mol Hum Reprod, 2004, 10 (7) :473 -479.
  • 6The Rotterdam ESHRE/ASRM -Sponsored PCOS consensus work shop group. Revised 2003 consensus on diagnostics criteria and long- term health risks related to polycystic ovary syndrome ( PCOS). Hum Reprod,2004,19( 1 ) :41 -47.
  • 7Azzia R. Poly dystic ovary syndrome, insulin resistance and mo- lecular defects of insulin signaling. Clin Endocrin Metab ,2002,87 (9) :4085 -4087.
  • 8Ewinler I,Aktas D, Otegen U,et al. CYP1A gene polymorphis m and polycystic ovary sysndrome. Reprod Biomed, 2008, 16 ( 3 ) : 356 - 360.
  • 9The rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group.Rivised2003consensus on diagnostic criteria and long term health risked related to polycystic ovary syndrome[J].Fertil Steril,2004,81:19-25.
  • 10Holland W,Morrison T,Chang Y,et al.Metformin(Glucophage)inhibits tyrosine phosphatase activity to stimulate the insu lin receptor tyrosine kinase[J].Biochem Pharmacol,2004,67(11):2081-2091.

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部